Answers
Diagnosis was renal cell carcinoma. Right kidney was removed with a radical nephrectomy.
since the affected kidney has already been removed, you have already "upped" your chances of survival. there is now a higher probability of recovering. however, precaution should still be exercised. visit your doctor and have a follow up exam to check wether the surgery was a success and if it was done in time to prevent the spread of the disease. since carcinoma is often caused by too much "bad" carbon in the body, you would do well by not eating "burned meat" that usually happens when cooking in open fire-such as when grilling. good luck!
www.medpagetoday.com Robert A. Figlin, MD, City of Hope, Duarte, Calif. CHICAGO -- In patients with treatment-naive advanced renal cell carcinoma ...
According to Medline Plus Medical Encylopedia, the 5-year survival rate is 60-75%.
My father has stage four renal cell carcinoma. After a radical nephrectomy, it spread to his arm bone, liver and lungs. In a few months it has grown and become very aggressive. He is currently in the hospital because he was having a very difficult time breathing. His skin and the whites of his eyes turned yellow. He is in constant pain, sleeps all the time, is to weak to reposition himself in bed. He has had four blood transfusions while in the hospital, he is being treated as a diabetic with insulin shots. He is on oxygen. His doctor was going to put a shunt in his liver to on block a blockage but after his ultrasound they found that his liver was just full of tumors. He tried a chemo therapy a few months ago that made him ery sick, and now his doctor wants to start another chemo treatment. I never get to see his doctors, they are either in the hospital too early or too late to see. My dad is confused and has a difficult time remebering things. I want to know what are chances that he can survive this? And if he can't why should he try more chemo that is going to make him sicker?? I need answers PLEASE! I just can' stand to see him suffer anymore.
One more chemo and your dad will die very soon. Chemotherapy, together with drug-based treatments, made him worse.
Try natural methods such as systemic enzyme therapy. Please see my reference.
My mother has had cancer for 2 years & a half. Today we found out that she has renal cell carcinoma (RCC). the cancer started in one of her kidney's and spread to her lungs.
she lost weight over the years & is very weak
can someone please tell me how long the survival rate with rcc is?
please help and any other advice would be great
It never serves any good purpose to speculate on life expectancy. All patients have different illness characteristics and respond differently to treatment.
As the previous post suggested, her oncologist is the correct person to discuss her treatment plan and prognosis with.
Best wishes.
1. A possible treatment of acute renal failure is:
A. Long-term dialysis
B. There is no cure; it will become chronic.
C. Short-term dialysis
D. It is always fatal.
2. The five-year survival rate for Adenocarcinoma of the kidney is:
A. 25
B. 50
C. 75
D. 90-100
3. The most common neoplasm of the urinary tract is:
A. Adenocarcinoma of the kidney.
B. Transitional Cell Carcinoma.
C. Basal Cell Carcinoma
D. Malignant Melanoma
4. What age group is most commonly affected by incontinence?
A. Mid-30's
B. Mid-50's
C. Seniors
D. Teenagers
5.Which of the following is not a possible contributor of incontinence?
A. Pregnancy
B. Enlarged prostate
C. Too much to eat
D. Kidney stones
6. Cystitis refers to:
A. any infection of the urinary tract.
B. infection of the urethra.
C. kidney infection.
D. bladder infection.
7. A supplement that might be needed when taking diuretics is:
A. iron.
B. salt.
C. potassium.
D. calcium.
8. Nocturia refers to:
A. frequent urination.
B. urination at night
C. lack of urination.
D. painful urination
LOL...here are your answers..
1. C.
2. Survival rate depends on stage. Overall, it is about 65%, so you pick which one you want to choose 50 or 75%
3. A
4. C
5. Bad question. Answer can be C or D.
6. D
7. C
8. B
Good luck.
Cancer Journal: Latest cancer research Combination versus single ...
Combination therapy for renal cell carcinoma does not improve overall or progression-free survival compared with single therapy using interferon alfa-2a alone. However, the combined regimen might still have a role because it can produce remissions that are of clinically relevant length in some patients. Thus identification of these patients is crucial. These are the conclusions of an article published in an upcoming edition of Renal cell carcinomas account for 2% of all malignant tumours in adults. 30% of patients with renal cell carcinoma present with metastatic disease (secondary tumours), and half of those who apparently have localised disease at diagnosis subsequently develop metastases....
News
Prognostic model for survival in patients with metastatic renal cell carcinoma ...UroToday - Sep 26, 2011
To develop a single validated model for survival in metastatic renal cell carcinoma (mRCC) using a comprehensive international database. A comprehensive database of 3748 patients including previously reported clinical prognostic factors was establishedMarketWatch (press release) - Sep 28, 2011
Archexin has FDA Orphan drug designation for five different cancer types, including renal cell carcinoma, glioblastoma, pancreatic, stomach and ovarian cancers. Rexahn Pharmaceuticals is a clinical stage pharmaceutical company dedicated to developing and morenbsp;raquo;Doctors Lounge - Sep 23, 2011
The levels of certain serum amino acids are significantly different in patients with renal cell carcinoma and show potential as biomarkers with predictive value for tumor recurrence and overall survival, according to a study published in the October and morenbsp;raquo;UroToday - Sep 28, 2011
We aimed to describe the efficacy and safety of sunitinib in unselected Korean advanced renal cell carcinoma (RCC) patients. From November 2005 to August 2008, 132 histologically confirmed advanced RCC patients (100 in the global expanded accessMedscape - Sep 26, 2011
msnbc.com#39;Strongest Ever Data#39; in Breast Cancer With EverolimusEverolimus is an mTOR inhibitor that has already been approved in the United States for the treatment of progressive neuroendocrine tumors of pancreatic origin and advanced renal cell carcinoma in certain patients. Exemestane is an aromatase inhibitor, Novartis#39; Afinitor More Than Doubles Progression-free Survival In Breast CancerAfinitor (Everolimus) Prolongs Advanced Breast Cancer Patients#39; Progression Novartis Drug Afinitor® Helps Women With Advanced Breast Cancer Live all 299 news articlesnbsp;raquo;
7thSpace Interactive (press release) - Sep 28, 2011
Protein kinase C epsilon (PKCepsilon), an oncogene overexpressed in several human cancers, is involved in cell proliferation, migration, invasion, and survival. However, its roles in clear cell renal cell carcinoma (RCC) are unclear.Inventorspot - Sep 28, 2011
Afinitor® Stops Tumor Growth amp; Lengthens Lives For Breast Cancer Patientsby T Goodman Microscopic image of breast cancer cell: image via alternative-cancer.netAfinitor®, the Novartis trademark for the cancer fighter, everolimus, is used for the treatment of advanced renal cell carcinoma (RCC), inoperable cases of certain and morenbsp;raquo;